Search

Your search keyword '"Pathologie Groep Brosens"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Pathologie Groep Brosens" Remove constraint Author: "Pathologie Groep Brosens"
42 results on '"Pathologie Groep Brosens"'

Search Results

1. DNA Methylation Profiling Enables Accurate Classification of Nonductal Primary Pancreatic Neoplasms

2. Long-term restoration of bowel continuity after rectal cancer resection and the influence of surgical technique: A nationwide cross-sectional study

3. Impact of the new rectal cancer definition on multimodality treatment and interhospital variability: Results from a nationwide cross-sectional study

5. Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites

6. Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting

7. Diagnostic Utility of Menin Immunohistochemistry in Patients With Multiple Endocrine Neoplasia Type 1 Syndrome

8. Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification

9. Status of Surveillance and Nonsurgical Therapy for Small Nonfunctioning Pancreatic Neuroendocrine Tumors

11. Reply to 'von Hippel-Lindau disease integrated care pathway: Centralizing, expanding specialists' theatre, and measuring improvement'

12. Retrospective evaluation of national MRI reporting quality for lateral lymph nodes in rectal cancer patients and concordance with prospective re-evaluation following additional training

13. Prognostic and Predictive Biomarkers for Pancreatic Neuroendocrine Tumors

14. Multidisciplinary integrated care pathway for von Hippel–Lindau disease

15. Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring

17. Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System

18. Metastatic patterns of duodenopancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1

19. Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size

20. The Impact of Clinical and Pathological Features on Intraductal Papillary Mucinous Neoplasm Recurrence After Surgical Resection: Long-Term Follow-Up Analysis

21. Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer

23. Genome methylation accurately predicts neuroendocrine tumor origin - an online tool

24. The management of neuroendocrine tumors of the lung in MEN1: results from the Dutch MEN1 Study Group

25. Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration

26. The decisive role of molecular pathology in presumed somatic metastases of type II testicular germ cell tumors: Report of 2 cases

27. Genomic characterization of malignant progression in neoplastic pancreatic cysts

28. Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas

29. Clear cell chondrosarcoma in Von Hippel-Lindau disease

30. Well-differentiated Pancreatic Neuroendocrine Tumor in a Patient With Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM)

31. Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation Carriers

32. Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors (Nature Medicine, (2019), 25, 8, (1260-1265), 10.1038/s41591-019-0493-4)

33. Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors

34. SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival

35. The theranostic target prostate-specific membrane antigen is expressed in medullary thyroid cancer

36. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment

38. Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial): a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)

39. Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)

40. Successful treatment of leptomeningeally metastasised pituitary carcinoma with temozolomide

41. Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas

42. Additional Candidate Genes for Human Atherosclerotic Disease Identified Through Annotation Based on Chromatin Organization

Catalog

Books, media, physical & digital resources